π¬Deep Research
QGEN β Qiagen Β· catalysts, narrative & risks
Qiagen (QGEN) β Point-in-Time Research Note (as of 2026-10-04)
Snapshot. Qiagen N.V. trades on the NYSE under ticker QGEN (ISIN NL0015002SN0). As of October 2, 2026 the share traded around $45.29 intraday (up ~7.7% on the day) per [1], or roughly $44.75 at the Oct 2 close (up ~6.45%), implying a market capitalization of about $9.2β9.3 billion [1], [14]. The two sources report slightly different intraday vs. closing figures. Classification varies by source β diagnostics/research [1], biotechnology [21] β though the internal universe file lists it under healthcare_services.
Recent Catalysts (JulyβOctober 2026)
AI-assisted research from the K3vl4r desk β not personalized investment advice. More research β